MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)
NCT02066012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2014-02-19
Summary
Dysmetabolic iron overload syndrome (DIOS), is a frequent hepatic iron overload associated with metabolic syndrome. We hypothesize that this mild iron overload can induce a increased macrophagic polarization towards inflammatory types, thereby contributing to cardiovascular risk. Our main objective is to highlight the influence of iron overload on polarization capacity of monocytes into alternative macrophages (called M2). We therefore compare phenotypic markers of monocytes/macrophages between subjects with DIOS, metabolic syndrome without iron overload and lean subjects.
Conditions
- Dysmetabolic Iron Overload Syndrome
- Metabolic Syndrome X
Interventions
- OTHER
-
dysmetabolic iron overload syndrome
Sponsors & Collaborators
-
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
collaborator OTHER -
University Hospital, Clermont-Ferrand
lead OTHER
Principal Investigators
-
Marc RUIVARD · University Hospital, Clermont-Ferrand
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-08-31
- Completion
- 2014-10-31
Countries
- France
Study Locations
More Related Trials
-
Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist
NCT04594356 ·Status: COMPLETED
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
NCT03892785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH
NCT04347460 ·Status: UNKNOWN
-
Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies
NCT05182515 ·Status: UNKNOWN ·Phase: PHASE3
-
Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
NCT00843856 ·Status: COMPLETED ·Phase: PHASE4
-
From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP
NCT04174066 ·Status: UNKNOWN
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)
NCT02933021 ·Status: UNKNOWN
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
MoMa Signature During Granulomatosis
NCT05916638 ·Status: RECRUITING
-
Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
NCT01240850 ·Status: UNKNOWN ·Phase: PHASE3
-
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
NCT01446380 ·Status: UNKNOWN
-
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
NCT07117981 ·Status: RECRUITING
-
Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
NCT03240991 ·Status: COMPLETED
-
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
NCT05074706 ·Status: COMPLETED
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis
NCT06131112 ·Status: RECRUITING
-
Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.
NCT01910038 ·Status: COMPLETED ·Phase: PHASE2
-
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
NCT04299971 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Response of Dasatinib to Treat Mastocytosis
NCT00979160 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis
NCT00441961 ·Status: COMPLETED ·Phase: NA
-
Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
NCT02837965 ·Status: COMPLETED